Stakeholder engagement, dissemination and communication (Work Package 4)


P1vital® PReDicT Communication & Dissemination

WP4 Objectives:

  • Disseminate and communicate any information concerning the project, results and findings to stakeholders
  • Engage with stakeholders to:
    • Maximise the probability of rapid market adoption across Europe and identify early adopters
    • Secure additional funding or investment to conduct further studies to strengthen and expand the P1vital® PReDicT Test market
    • Attract commercial collaborations to increase global market penetration

 

WP4 Lead:  Dr Amy Bilderbeck

 

WP4 Partners:

  • WP2 study investigators to facil­it­ate com­mu­nic­a­tion within each coun­try

 

News:

Oxford University article talks about PReDicT Clinical Study

Oxford University article talks about PReDicT Project run by P1vital Products Limited and P1vital® PReDicT Test which is being used in clinical study across 5 European countries: France, Germany, Spain, The Netherlands and the UK.

To read the full article, click here

NHS Foundation Trust discusses PReDicT Project

Oxford Health NHS Foundation Trust about PReDicT Project discusses P1vital Products Limited and P1vital® PReDicT Test which is being used in clinical study across 5 European countries.

To read the full article, click here

 

Horizon 2020 Emblem